\-\ Texto\\:\\ \ \(0\)\
\-\ a\\ lateral\\ view\\ of\\ the\\ pharynx\\ during\\ phonation\\ \\(films\\ \\.1\\ and\\ \\.3\\)\\ shows\\ multiple\\,\\ irregular\\,\\ 2\\-4\\ mm\\ nodules\\ in\\ the\\ oropharynx\\ and\\ in\\ the\\ tonsillar\\ fossa\\.\\ \\ a\\ single\\ view\\ of\\ the\\ mid\\ esophagus\\ \\(film\\ \\.2\\)\\ shows\\ multiple\\ small\\,\\ well\\-circumscribed\\ plaques\\ aligned\\ longitudinally\\ along\\ mucosal\\ folds\\.\\ \\ barium\\ has\\ coated\\ the\\ laryngeal\\ vestibule\\ and\\ trachea\\.\ \(0\)\
\-\ candida\\ pharyngitis\\ and\\ candida\\ esophagitis\\ in\\ an\\ immunosuppressed\\ patient\\.\ \(0\)\
\-\ 65\\-year\\-old\\ woman\\ with\\ metastatic\\ breast\\ carcinoma\\ and\\ dysphagia\\.\\ \\ look\\ at\\ films\\ \\.1\\ and\\ \\.2\\.\\ \\ what\\ is\\ the\\ diagnosis\\?\ \(0\)\
\-\ barium\\ studies\\ of\\ the\\ pharynx\\ are\\ usually\\ of\\ limited\\ value\\ in\\ patients\\ with\\ acute\\ sore\\ throat\\ due\\ to\\ viral\\,\\ bacterial\\,\\ or\\ fungal\\ infection\\.\\ \\ such\\ patients\\ usually\\ have\\ normal\\ pharyngograms\\ or\\ nonspecific\\ lymphoid\\ hyperplasia\\ of\\ the\\ palatine\\ or\\ lingual\\ tonsils\\.\\ a\\ double\\ contrast\\ examination\\ of\\ the\\ pharynx\\,\\ however\\,\\ may\\ demonstrate\\ the\\ plaques\\ of\\ candida\\ pharyngitis\\ or\\ the\\ ulcers\\ of\\ herpes\\ pharyngitis\\,\\ particularly\\ in\\ immunosuppressed\\ patients\\ and\\/or\\ patients\\ with\\ acquired\\ immunodeficiency\\ syndrome\\ \\(aids\\)\\.\\ \\ barium\\ studies\\ may\\ also\\ be\\ helpful\\ to\\ determine\\ whether\\ there\\ is\\ underlying\\ gastroesophageal\\ reflux\\ or\\ reflux\\ esophagitis\\ in\\ patients\\ who\\ have\\ chronic\\ sore\\ throat\\.\ \(0\)\
\-\ inflammatory\\ disorders\\ of\\ the\\ pharynx\\ can\\ alter\\ pharyngeal\\ elevation\\,\\ epiglottic\\ tilt\\ or\\ vocal\\ cord\\ and\\ laryngeal\\ vestibule\\ closure\\.\\ \\ thus\\,\\ pharyngeal\\ dysmotility\\ due\\ to\\ a\\ local\\ inflammatory\\ process\\ may\\ result\\ in\\ laryngeal\\ penetration\\,\\ as\\ in\\ this\\ case\\.\\ pharyngeal\\ dysmotility\\ is\\ common\\ following\\ radiation\\ therapy\\ or\\ in\\ patients\\ with\\ marked\\ gastroesophageal\\ reflux\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pharynx\\:\\ 0\\.2914195607910781\ \(0\)\
\-\ pharyngitis\\:\\ 0\\.24792987644251915\ \(0\)\
\-\ candida\\:\\ 0\\.23237036410011083\ \(0\)\
\-\ laryngeal\\:\\ 0\\.2237730631406545\ \(0\)\
\-\ patients\\:\\ 0\\.20568457344894125\ \(0\)\
\-\ pharyngeal\\:\\ 0\\.20557035999942608\ \(0\)\
\-\ immunosuppressed\\:\\ 0\\.17532834130696565\ \(0\)\
\-\ dysmotility\\:\\ 0\\.17143299102147108\ \(0\)\
\-\ or\\:\\ 0\\.16959299396242195\ \(0\)\
\-\ barium\\:\\ 0\\.16278636167901633\ \(0\)\
\-\ vestibule\\:\\ 0\\.16277011729221608\ \(0\)\
\-\ reflux\\:\\ 0\\.15833173780307963\ \(0\)\
\-\ the\\:\\ 0\\.14591123688820057\ \(0\)\
\-\ esophagitis\\:\\ 0\\.14570978039553906\ \(0\)\
\-\ sore\\:\\ 0\\.1392979631072478\ \(0\)\
\-\ in\\:\\ 0\\.13643379250618684\ \(0\)\
\-\ gastroesophageal\\:\\ 0\\.13199639530431248\ \(0\)\
\-\ plaques\\:\\ 0\\.12296194220106998\ \(0\)\
\-\ throat\\:\\ 0\\.12223762621057076\ \(0\)\
\-\ of\\:\\ 0\\.10732705994154829\ \(0\)\
\-\ and\\:\\ 0\\.1007361587506276\ \(0\)\
\-\ pharyngograms\\:\\ 0\\.09745257260321967\ \(0\)\
\-\ epiglottic\\:\\ 0\\.09745257260321967\ \(0\)\
\-\ films\\:\\ 0\\.09651441558463875\ \(0\)\
\-\ palatine\\:\\ 0\\.09312113573859218\ \(0\)\
\-\ may\\:\\ 0\\.09199724477165426\ \(0\)\
\-\ studies\\:\\ 0\\.08940203469903682\ \(0\)\
\-\ view\\:\\ 0\\.08924942493966509\ \(0\)\
\-\ phonation\\:\\ 0\\.08766417065348282\ \(0\)\
\-\ immunodeficiency\\:\\ 0\\.08766417065348282\ \(0\)\
\-\ coated\\:\\ 0\\.08406975964133723\ \(0\)\
\-\ aligned\\:\\ 0\\.08264329214750639\ \(0\)\
\-\ inflammatory\\:\\ 0\\.08241104071288043\ \(0\)\
\-\ lingual\\:\\ 0\\.08138505864610804\ \(0\)\
\-\ longitudinally\\:\\ 0\\.08025953042562617\ \(0\)\
\-\ tilt\\:\\ 0\\.08025953042562617\ \(0\)\
\-\ alter\\:\\ 0\\.07924136630219536\ \(0\)\
\-\ usually\\:\\ 0\\.07672502012544366\ \(0\)\
\-\ lymphoid\\:\\ 0\\.07459102104688484\ \(0\)\
\-\ vocal\\:\\ 0\\.0734028378800129\ \(0\)\
\-\ tonsillar\\:\\ 0\\.07285489019776953\ \(0\)\
\-\ shows\\:\\ 0\\.07153026070520457\ \(0\)\
\-\ penetration\\:\\ 0\\.07047112847588931\ \(0\)\
\-\ due\\:\\ 0\\.07005620900024076\ \(0\)\
\-\ herpes\\:\\ 0\\.0681731715344867\ \(0\)\
\-\ tonsils\\:\\ 0\\.0678340116917931\ \(0\)\
\-\ oropharynx\\:\\ 0\\.06657577819039476\ \(0\)\
\-\ aids\\:\\ 0\\.066283084874797\ \(0\)\
\-\ folds\\:\\ 0\\.06572071094088613\ \(0\)\
\-\ closure\\:\\ 0\\.06443208584648207\ \(0\)\
\-\ ulcers\\:\\ 0\\.06419201646851452\ \(0\)\
\-\ value\\:\\ 0\\.06204832412460186\ \(0\)\
\-\ look\\:\\ 0\\.06129835746165035\ \(0\)\
\-\ have\\:\\ 0\\.060883399955895874\ \(0\)\
\-\ whether\\:\\ 0\\.05962578690557053\ \(0\)\
\-\ multiple\\:\\ 0\\.05961186422665505\ \(0\)\
\-\ trachea\\:\\ 0\\.059023788899018326\ \(0\)\
\-\ acquired\\:\\ 0\\.058735051383405165\ \(0\)\
\-\ what\\:\\ 0\\.05859355742429961\ \(0\)\
\-\ helpful\\:\\ 0\\.0577818275069906\ \(0\)\
\-\ particularly\\:\\ 0\\.05752440209313979\ \(0\)\
\-\ mucosal\\:\\ 0\\.05739797886929133\ \(0\)\
\-\ nonspecific\\:\\ 0\\.057273034313551845\ \(0\)\
\-\ bacterial\\:\\ 0\\.057027445618625425\ \(0\)\
\-\ determine\\:\\ 0\\.05666933484363119\ \(0\)\
\-\ viral\\:\\ 0\\.056209795702419386\ \(0\)\
\-\ thus\\:\\ 0\\.05598723269946983\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.05555555224031534\ \(0\)\
\-\ elevation\\:\\ 0\\.05555555224031534\ \(0\)\
\-\ dysphagia\\:\\ 0\\.05503938238339808\ \(0\)\
\-\ fungal\\:\\ 0\\.05454700778231286\ \(0\)\
\-\ disorders\\:\\ 0\\.05380356785714575\ \(0\)\
\-\ double\\:\\ 0\\.05371417287742873\ \(0\)\
\-\ local\\:\\ 0\\.052455939376030394\ \(0\)\
\-\ esophagus\\:\\ 0\\.050183538996425164\ \(0\)\
\-\ is\\:\\ 0\\.050064570490210535\ \(0\)\
\-\ underlying\\:\\ 0\\.04974489400805085\ \(0\)\
\-\ limited\\:\\ 0\\.048637800024647806\ \(0\)\
\-\ nodules\\:\\ 0\\.0484186613099217\ \(0\)\
\-\ fossa\\:\\ 0\\.047838227121943695\ \(0\)\
\-\ with\\:\\ 0\\.047729416815239435\ \(0\)\
\-\ irregular\\:\\ 0\\.047046558502054\ \(0\)\
\-\ single\\:\\ 0\\.046857480331815464\ \(0\)\
\-\ marked\\:\\ 0\\.04608926427400463\ \(0\)\
\-\ process\\:\\ 0\\.04570387683174077\ \(0\)\
\-\ to\\:\\ 0\\.04570288031766524\ \(0\)\
\-\ result\\:\\ 0\\.04562009100822316\ \(0\)\
\-\ film\\:\\ 0\\.04553695722106771\ \(0\)\
\-\ cord\\:\\ 0\\.045170659470782255\ \(0\)\
\-\ breast\\:\\ 0\\.044251155606985684\ \(0\)\
\-\ mid\\:\\ 0\\.043854789684905006\ \(0\)\
\-\ mm\\:\\ 0\\.043610004951426654\ \(0\)\
\-\ along\\:\\ 0\\.04082589429783029\ \(0\)\
\-\ radiation\\:\\ 0\\.04038235112327529\ \(0\)\
\-\ such\\:\\ 0\\.039198203963404184\ \(0\)\
\-\ examination\\:\\ 0\\.03899428740143245\ \(0\)\
\-\ during\\:\\ 0\\.038597772854450214\ \(0\)\
\-\ infection\\:\\ 0\\.0368098682154484\ \(0\)\
\-\ syndrome\\:\\ 0\\.0367369489034007\ \(0\)\
\-\ following\\:\\ 0\\.036556798972491984\ \(0\)\
\-\ carcinoma\\:\\ 0\\.03645014945704836\ \(0\)\
\-\ chronic\\:\\ 0\\.0361708489011799\ \(0\)\
\-\ however\\:\\ 0\\.03606796555953265\ \(0\)\
\-\ therapy\\:\\ 0\\.03501263362451805\ \(0\)\
\-\ common\\:\\ 0\\.0345586288541717\ \(0\)\
\-\ who\\:\\ 0\\.0344700982004988\ \(0\)\
\-\ metastatic\\:\\ 0\\.03342125406997365\ \(0\)\
\-\ acute\\:\\ 0\\.032964940257034274\ \(0\)\
\-\ can\\:\\ 0\\.03197814954157577\ \(0\)\
\-\ woman\\:\\ 0\\.031736528694905154\ \(0\)\
\-\ demonstrate\\:\\ 0\\.03167979655022376\ \(0\)\
\-\ diagnosis\\:\\ 0\\.031589647173575805\ \(0\)\
\-\ small\\:\\ 0\\.031433693487974784\ \(0\)\
\-\ case\\:\\ 0\\.030614414003046767\ \(0\)\
\-\ lateral\\:\\ 0\\.030242018692460456\ \(0\)\
\-\ contrast\\:\\ 0\\.029608361186941393\ \(0\)\
\-\ also\\:\\ 0\\.028663325331676003\ \(0\)\
\-\ has\\:\\ 0\\.027834544113482143\ \(0\)\
\-\ normal\\:\\ 0\\.024880434935073616\ \(0\)\
\-\ be\\:\\ 0\\.024719969487394782\ \(0\)\
\-\ as\\:\\ 0\\.02448081773229835\ \(0\)\
\-\ there\\:\\ 0\\.024246902833968877\ \(0\)\
\-\ an\\:\\ 0\\.02330235378614579\ \(0\)\
\-\ are\\:\\ 0\\.023123067717181225\ \(0\)\
\-\ at\\:\\ 0\\.023016922820968774\ \(0\)\
\-\ this\\:\\ 0\\.020939274815617557\ \(0\)\
\-\ patient\\:\\ 0\\.019819959237204532\ \(0\)\
